Company / Current Liabilities per Share
Arcutis Biotherapeutics, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.10
FY2025
5-year range
$0.67 / $1.10
FY2021-FY2025
Trend
+31.6%
vs FY2024
Sector context
#107 of 210
Health Care
What the data says
At $1.10, Arcutis Biotherapeutics, Inc.'s current liabilities per share ranks #104 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 7 years, ranging from $0.63 in FY2020 to $2.84 in FY2019.
Based on SEC 10-K filings.
1.10 in FY2025 with a 5-year CAGR of +11.7%.
Increased from $0.67 to $1.10 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
-93.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 31.6% year-over-year.
- Ranks #107 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.10 | +31.6% |
| FY2024 | $0.84 | +24.3% |
| FY2023 | $0.67 | -2.0% |
| FY2022 | $0.69 | +1.8% |
| FY2021 | $0.67 | +6.4% |
| FY2020 | $0.63 | -77.7% |
| FY2019 | $2.84 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026